step 11 semaglutide Once-weekly 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial Henry Meds Semaglutide Review [2026]
Pay in 4 interest-free payments of $5.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
![step 11 semaglutide Once-weekly 24 mg in an Asian population with obesity, defined as BMI 25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial Henry Meds Semaglutide Review [2026]](https://innerbody.imgix.net/henry-semaglutide-with-ondansteron-close-up.jpg)
![step 11 semaglutide Once-weekly 24 mg in an Asian population with obesity, defined as BMI 25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial Henry Meds Semaglutide Review [2026]](https://ars.els-cdn.com/content/image/1-s2.0-S2213858725002268-gr2.jpg)
![step 11 semaglutide Once-weekly 24 mg in an Asian population with obesity, defined as BMI 25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial Henry Meds Semaglutide Review [2026]](https://primary.jwwb.nl/public/i/y/p/temp-xjvpieeyphiswknjweya/whatsapp-image-2025-09-02-at-11-23-00-am-standard.jpg)
![step 11 semaglutide Once-weekly 24 mg in an Asian population with obesity, defined as BMI 25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial Henry Meds Semaglutide Review [2026]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20a/12094194/2132001e1741/dc242425F0GA.jpg)
![step 11 semaglutide Once-weekly 24 mg in an Asian population with obesity, defined as BMI 25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial Henry Meds Semaglutide Review [2026]](https://www.frontiersin.org/files/Articles/1398059/xml-images/fnut-11-1398059-g001.webp)
![step 11 semaglutide Once-weekly 24 mg in an Asian population with obesity, defined as BMI 25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial Henry Meds Semaglutide Review [2026]](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40262-018-0728-4/MediaObjects/40262_2018_728_Fig1_HTML.png)




















